Astria Therapeutics to Present at Upcoming 6th Annual Evercore ISI HealthCONx Conference

Rhea-AI Summary

Astria Therapeutics, Inc. (ATXS) CEO Jill C. Milne, Ph.D., to present corporate overview and information on STAR-0215 and STAR-0310 at 6th Annual Evercore ISI HealthCONx Conference

BOSTON--(BUSINESS WIRE)-- Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today announced that Jill C. Milne, Ph.D., Chief Executive Officer, will present a corporate overview and information on STAR-0215 and STAR-0310 at the 6^th Annual Evercore ISI HealthCONx Conference on Thursday, November 30, at 8:45am ET in Miami, FL.

A webcast of the presentation can be accessed at the following link: https://wsw.com/webcast/evercore39/atxs/2402272. An archived replay of the presentation will be available in the investors section of www.astriatx.com for 30 days following the event.

About Astria Therapeutics:

Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development for the treatment of hereditary angioedema. Our second program, STAR-0310, is a monoclonal antibody OX40 antagonist in preclinical development for the treatment of atopic dermatitis. Learn more about our company on our website, www.astriatx.com, or follow us on X and Instagram @AstriaTx and on Facebook and LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231121631663/en/

Astria:

Investor Relations and Media:

Elizabeth Higgins

investors@astriatx.com

Source: Astria Therapeutics, Inc.

FAQ

What is Astria Therapeutics, Inc.'s (ATXS) focus?

Astria Therapeutics, Inc. (ATXS) is a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases.

When and where will Jill C. Milne, Ph.D., present a corporate overview and information on STAR-0215 and STAR-0310?

Jill C. Milne, Ph.D., will present at the 6th Annual Evercore ISI HealthCONx Conference on Thursday, November 30, at 8:45am ET in Miami, FL.

Where can I access the webcast of the presentation?

The webcast of the presentation can be accessed at the following link: https://wsw.com/webcast/evercore39/atxs/2402272.

How long will the archived replay of the presentation be available?

An archived replay of the presentation will be available in the investors section of www.astriatx.com for 30 days following the event.